Razelle Kurzrock, Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center shared a post on X:
“The power of a national immunotherapy trial providing clinical trial options for patients with rare cancers. And new guidelines. NCI/SWOG, DART hit the target.”
